Skip to main content

Advertisement

SpringerLink
Log in

Radiotherapy for prolactin-secreting pituitary tumors

  • Published:
Pituitary Aims and scope Submit manuscript

Abstract

Review the medical and surgical management of patients with prolactinomas and provide an in-depth appraisal of the role of radiotherapy in the treatment of prolactinomas. A thorough review of the pertinent literature was carried out and relevant topics were identified. Topics covered in this comprehensive review include: indications for the use of radiotherapy, choice between conventional radiotherapy and stereotactic radiosurgery, as well as the benefits and potential complications associated with each modality. Due to the excellent response rates with medical management, and rapid symptom relief afforded by resection or debulking surgery in patients who do not respond or tolerate medical therapy, radiotherapy is reserved for patients who do not respond to dopamine agonists and surgery. Both external beam radiotherapy and stereotactic radiosurgery retain important roles in the treatment of refractory or recurrent prolactinomas. Choosing the optimal approach is crucial in maximizing tumor control outcomes and minimizing the risks associated with treatment. The primary determinants of optimal radiation approach are proximity of the tumor to the optic apparatus and tumor size, with radiosurgery being our recommended treatment of choice unless the tumor is larger than 3–4 cm or within 3 mm of the optic nerves, chiasm or tracts. Optimal multidisciplinary management requires the identification of appropriate candidates for radiotherapy in order to take full advantage of treatment options available for each patient.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Casanueva FF, Molitch ME, Schlechte JA, Abs R, Bonert V, Bronstein MD, Brue T, Cappabianca P, Colao A, Fahlbusch R, Fideleff H, Hadani M, Kelly P, Kleinberg D, Laws E, Marek J, Scanlon M, Sobrinho LG, Wass JA, Giustina A (2006) Guidelines of the pituitary society for the diagnosis and management of prolactinomas. Clin Endocrinol (Oxf) 65(2):265–273. doi:10.1111/j.1365-2265.2006.02562.x

    Article  Google Scholar 

  2. Melmed S, Casanueva FF, Hoffman AR, Kleinberg DL, Montori VM, Schlechte JA, Wass JA (2011) Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 96(2):273–288. doi:10.1210/jc.2010-1692

    Article  PubMed  CAS  Google Scholar 

  3. Klibanski A (2010) Clinical practice. Prolactinomas. N Engl J Med 362(13):1219–1226. doi:10.1056/NEJMcp0912025

    Article  PubMed  CAS  Google Scholar 

  4. Colao A, Savastano S (2011) Medical treatment of prolactinomas. Nat Rev Endocrinol 7(5):267–278. doi:10.1038/nrendo.2011.37

    Article  PubMed  CAS  Google Scholar 

  5. Melmed S (2002) The pituitary, 2nd edn. Blackwell Pub, Malden

    Google Scholar 

  6. Vandeva S, Jaffrain-Rea ML, Daly AF, Tichomirowa M, Zacharieva S, Beckers A (2010) The genetics of pituitary adenomas. Best Pract Res Clin Endocrinol Metab 24(3):461–476. doi:10.1016/j.beem.2010.03.001

    Article  PubMed  CAS  Google Scholar 

  7. Karthikeyan M, Arunakaran J, Balasubramanian K (2009) The effects of prolactin and corticosterone on insulin binding to rat Leydig cells. Reprod Biol 9(2):189–194

    PubMed  Google Scholar 

  8. Huang WJ, Yeh JY, Kan SF, Chang LS, Wang PS (2001) Effects of hyperprolactinemia on testosterone production in rat Leydig cells. J Cell Biochem 80(3):313–320. doi:10.1002/1097-4644(20010301)80:3<313:AID-JCB30>3.0.CO;2-E

    Article  PubMed  CAS  Google Scholar 

  9. Vilar L, Freitas MC, Naves LA, Casulari LA, Azevedo M, Montenegro R Jr, Barros AI, Faria M, Nascimento GC, Lima JG, Nobrega LH, Cruz TP, Mota A, Ramos A, Violante A, Lamounier Filho A, Gadelha MR, Czepielewski MA, Glezer A, Bronstein MD (2008) Diagnosis and management of hyperprolactinemia: results of a Brazilian multicenter study with 1234 patients. J Endocrinol Invest 31(5):436–444

    PubMed  CAS  Google Scholar 

  10. Colao A (2009) Pituitary tumours: the prolactinoma. Best Pract Res Clin Endocrinol Metab 23(5):575–596. doi:10.1016/j.beem.2009.05.003

    Article  PubMed  CAS  Google Scholar 

  11. Molitch ME, Elton RL, Blackwell RE, Caldwell B, Chang RJ, Jaffe R, Joplin G, Robbins RJ, Tyson J, Thorner MO (1985) Bromocriptine as primary therapy for prolactin-secreting macroadenomas: results of a prospective multicenter study. J Clin Endocrinol Metab 60(4):698–705

    Article  PubMed  CAS  Google Scholar 

  12. Bevan JS, Webster J, Burke CW, Scanlon MF (1992) Dopamine agonists and pituitary tumor shrinkage. Endocr Rev 13(2):220–240

    PubMed  CAS  Google Scholar 

  13. Verhelst J, Abs R, Maiter D, van den Bruel A, Vandeweghe M, Velkeniers B, Mockel J, Lamberigts G, Petrossians P, Coremans P, Mahler C, Stevenaert A, Verlooy J, Raftopoulos C, Beckers A (1999) Cabergoline in the treatment of hyperprolactinemia: a study in 455 patients. J Clin Endocrinol Metab 84(7):2518–2522

    Article  PubMed  CAS  Google Scholar 

  14. Barker FG 2nd, Klibanski A, Swearingen B (2003) Transsphenoidal surgery for pituitary tumors in the United States, 1996–2000: mortality, morbidity, and the effects of hospital and surgeon volume. J Clin Endocrinol Metab 88(10):4709–4719

    Article  PubMed  CAS  Google Scholar 

  15. Gittoes NJ, Sheppard MC, Johnson AP, Stewart PM (1999) Outcome of surgery for acromegaly—the experience of a dedicated pituitary surgeon. QJM 92(12):741–745

    Article  PubMed  CAS  Google Scholar 

  16. Yamada S, Aiba T, Takada K, Ozawa Y, Shimizu T, Sawano S, Shishiba Y, Sano T (1996) Retrospective analysis of long-term surgical results in acromegaly: preoperative and postoperative factors predicting outcome. Clin Endocrinol (Oxf) 45(3):291–298

    Article  CAS  Google Scholar 

  17. Rees DA, Hanna FW, Davies JS, Mills RG, Vafidis J, Scanlon MF (2002) Long-term follow-up results of transsphenoidal surgery for Cushing’s disease in a single centre using strict criteria for remission. Clin Endocrinol (Oxf) 56(4):541–551

    Article  CAS  Google Scholar 

  18. Swords FM, Monson JP, Besser GM, Chew SL, Drake WM, Grossman AB, Plowman PN (2009) Gamma knife radiosurgery: a safe and effective salvage treatment for pituitary tumours not controlled despite conventional radiotherapy. Eur J Endocrinol 161(6):819–828. doi:10.1530/EJE-09-0493

    Article  PubMed  CAS  Google Scholar 

  19. Jenkins PJ, Bates P, Carson MN, Stewart PM, Wass JA (2006) Conventional pituitary irradiation is effective in lowering serum growth hormone and insulin-like growth factor-I in patients with acromegaly. J Clin Endocrinol Metab 91(4):1239–1245. doi:10.1210/jc.2005-1616

    Article  PubMed  CAS  Google Scholar 

  20. Barrande G, Pittino-Lungo M, Coste J, Ponvert D, Bertagna X, Luton JP, Bertherat J (2000) Hormonal and metabolic effects of radiotherapy in acromegaly: long-term results in 128 patients followed in a single center. J Clin Endocrinol Metab 85(10):3779–3785

    Article  PubMed  CAS  Google Scholar 

  21. Estrada J, Boronat M, Mielgo M, Magallon R, Millan I, Diez S, Lucas T, Barcelo B (1997) The long-term outcome of pituitary irradiation after unsuccessful transsphenoidal surgery in Cushing’s disease. N Engl J Med 336(3):172–177. doi:10.1056/NEJM199701163360303

    Article  PubMed  CAS  Google Scholar 

  22. Castinetti F, Nagai M, Morange I, Dufour H, Caron P, Chanson P, Cortet-Rudelli C, Kuhn JM, Conte-Devolx B, Regis J, Brue T (2009) Long-term results of stereotactic radiosurgery in secretory pituitary adenomas. J Clin Endocrinol Metab 94(9):3400–3407. doi:10.1210/jc.2008-2772

    Article  PubMed  CAS  Google Scholar 

  23. Witt TC (2003) Stereotactic radiosurgery for pituitary tumors. Neurosurg Focus 14(5):e10

    Article  PubMed  Google Scholar 

  24. Kong DS, Lee JI, Lim do H, Kim KW, Shin HJ, Nam DH, Park K, Kim JH (2007) The efficacy of fractionated radiotherapy and stereotactic radiosurgery for pituitary adenomas: long-term results of 125 consecutive patients treated in a single institution. Cancer 110(4):854–860. doi:10.1002/cncr.22860

    Article  PubMed  Google Scholar 

  25. Gillam MP, Molitch ME, Lombardi G, Colao A (2006) Advances in the treatment of prolactinomas. Endocr Rev 27(5):485–534. doi:10.1210/er.2005-9998

    Article  PubMed  CAS  Google Scholar 

  26. Pouratian N, Sheehan J, Jagannathan J, Laws ER Jr, Steiner L, Vance ML (2006) Gamma knife radiosurgery for medically and surgically refractory prolactinomas. Neurosurgery 59(2):255–266. doi:10.1227/01.NEU.0000223445.22938.BD discussion 255-266

    Article  PubMed  Google Scholar 

  27. Antunes J, Housepian J, Frantz E (1977) Prolactin-secreting pituitary tumors. Ann Neurol 2(2):148–153

    Article  Google Scholar 

  28. Gomez F, Reyes FI, Faiman C (1977) Nonpuerperal galactorrhea and hyperprolactinemia. Clinical findings, endocrine features and therapeutic responses in 56 cases. Am J Med 62(5):648–660

    Article  PubMed  CAS  Google Scholar 

  29. Grossman A, Cohen BL, Charlesworth M, Plowman PN, Rees LH, Wass JA, Jones AE, Besser GM (1984) Treatment of prolactinomas with megavoltage radiotherapy. Br Med J (Clin Res Ed) 288(6424):1105–1109

    Article  CAS  Google Scholar 

  30. Johnston DG, Hall K, Kendall-Taylor P, Ross WM, Crombie AL, Cook DB, Watson MJ (1986) The long-term effects of megavoltage radiotherapy as sole or combined therapy for large prolactinomas: studies with high definition computerized tomography. Clin Endocrinol (Oxf) 24(6):675–685

    Article  CAS  Google Scholar 

  31. Wang C, Lam KS, Ma JT, Chan T, Liu MY, Yeung RT (1987) Long-term treatment of hyperprolactinaemia with bromocriptine: effect of drug withdrawal. Clin Endocrinol (Oxf) 27(3):363–371

    Article  CAS  Google Scholar 

  32. Mehta AE, Reyes FI, Faiman C (1987) Primary radiotherapy of prolactinomas. Eight- to 15-year follow-up. Am J Med 83(1):49–58

    Article  PubMed  CAS  Google Scholar 

  33. Tsagarakis S, Grossman A, Plowman PN, Jones AE, Touzel R, Rees LH, Wass JA, Besser GM (1991) Megavoltage pituitary irradiation in the management of prolactinomas: long-term follow-up. Clin Endocrinol (Oxf) 34(5):399–406

    Article  CAS  Google Scholar 

  34. Levy RP, Fabrikant JI, Frankel KA, Phillips MH, Lyman JT, Lawrence JH, Tobias CA (1991) Heavy-charged-particle radiosurgery of the pituitary gland: clinical results of 840 patients. Stereotact Funct Neurosurg 57(1–2):22–35

    Article  PubMed  CAS  Google Scholar 

  35. Ganz JC, Backlund EO, Thorsen FA (1993) The effects of Gamma Knife surgery of pituitary adenomas on tumor growth and endocrinopathies. Stereotact Funct Neurosurg 61(Suppl 1):30–37

    PubMed  Google Scholar 

  36. Zierhut D, Flentje M, Adolph J, Erdmann J, Raue F, Wannenmacher M (1995) External radiotherapy of pituitary adenomas. Int J Radiat Oncol Biol Phys 33(2):307–314

    Article  PubMed  CAS  Google Scholar 

  37. Wallace EA, Holdaway IM (1995) Treatment of macroprolactinomas at Auckland Hospital 1975–91. N Z Med J 108(994):50–52

    PubMed  CAS  Google Scholar 

  38. Tsang RW, Brierley JD, Panzarella T, Gospodarowicz MK, Sutcliffe SB, Simpson WJ (1996) Role of radiation therapy in clinical hormonally-active pituitary adenomas. Radiother Oncol 41(1):45–53

    Article  PubMed  CAS  Google Scholar 

  39. Lim YL, Leem W, Kim TS, Rhee BA, Kim GK (1998) Four years’ experiences in the treatment of pituitary adenomas with gamma knife radiosurgery. Stereotact Funct Neurosurg 70(Suppl 1):95–109

    Article  PubMed  Google Scholar 

  40. Martinez R, Bravo G, Burzaco J, Rey G (1998) Pituitary tumors and gamma knife surgery. Clinical experience with more than two years of follow-up. Stereotact Funct Neurosurg 70(Suppl 1):110–118

    Article  PubMed  Google Scholar 

  41. Morange-Ramos I, Regis J, Dufour H, Andrieu JM, Grisoli F, Jaquet P, Peragut JC (1998) Gamma-knife surgery for secreting pituitary adenomas. Acta Neurochir (Wien) 140(5):437–443

    Article  CAS  Google Scholar 

  42. Inoue HK, Kohga H, Hirato M, Sasaki T, Ishihara J, Shibazaki T, Ohye C, Andou Y (1999) Pituitary adenomas treated by microsurgery with or without Gamma Knife surgery: experience in 122 cases. Stereotact Funct Neurosurg 72(Suppl 1):125–131

    Article  PubMed  Google Scholar 

  43. Mokry M, Ramschak-Schwarzer S, Simbrunner J, Ganz JC, Pendl G (1999) A six year experience with the postoperative radiosurgical management of pituitary adenomas. Stereotact Funct Neurosurg 72(Suppl 1):88–100

    Article  PubMed  Google Scholar 

  44. Izawa M, Hayashi M, Nakaya K, Satoh H, Ochiai T, Hori T, Takakura K (2000) Gamma knife radiosurgery for pituitary adenomas. J Neurosurg 93(Suppl 3):19–22. doi:10.3171/jns.2000.93.supplement3.0019

    PubMed  Google Scholar 

  45. Landolt AM, Lomax N (2000) Gamma knife radiosurgery for prolactinomas. J Neurosurg 93(Suppl 3):14–18. doi:10.3171/jns.2000.93.supplement3.0014

    PubMed  Google Scholar 

  46. Zhang N, Pan L, Dai J, Wang B, Wang E, Zhang W, Cai P (2000) Gamma Knife radiosurgery as a primary surgical treatment for hypersecreting pituitary adenomas. Stereotact Funct Neurosurg 75(2–3):123–128

    Article  PubMed  CAS  Google Scholar 

  47. Feigl GC, Bonelli CM, Berghold A, Mokry M (2002) Effects of gamma knife radiosurgery of pituitary adenomas on pituitary function. J Neurosurg 97(Suppl 5):415–421. doi:10.3171/jns.2002.97.supplement5.0415

    PubMed  Google Scholar 

  48. Choi JY, Chang JH, Chang JW, Ha Y, Park YG, Chung SS (2003) Radiological and hormonal responses of functioning pituitary adenomas after gamma knife radiosurgery. Yonsei Med J 44(4):602–607

    PubMed  Google Scholar 

  49. Petrovich Z, Yu C, Giannotta SL, Zee CS, Apuzzo ML (2003) Gamma knife radiosurgery for pituitary adenoma: early results. Neurosurgery 53(1): 51–59; discussion 59–61

    Google Scholar 

  50. Muramatsu J, Yoshida M, Shioura H, Kawamura Y, Ito H, Takeuchi H, Kubota T, Maruyama I (2003) Clinical results of LINAC-based stereotactic radiosurgery for pituitary adenoma. Nippon Igaku Hoshasen Gakkai Zasshi 63(5):225–230

    PubMed  Google Scholar 

  51. Kuo JS, Chen JC, Yu C, Zelman V, Giannotta SL, Petrovich Z, MacPherson D, Apuzzo ML (2004) Gamma knife radiosurgery for benign cavernous sinus tumors: quantitative analysis of treatment outcomes. Neurosurgery 54(6):1385–1393; discussion 1393–1384

    Google Scholar 

  52. Colin P, Jovenin N, Delemer B, Caron J, Grulet H, Hecart AC, Lukas C, Bazin A, Bernard MH, Scherpereel B, Peruzzi P, Nakib I, Redon C, Rousseaux P (2005) Treatment of pituitary adenomas by fractionated stereotactic radiotherapy: a prospective study of 110 patients. Int J Radiat Oncol Biol Phys 62(2):333–341. doi:10.1016/j.ijrobp.2004.09.058

    Article  PubMed  Google Scholar 

  53. Ma ZM, Qiu B, Hou YH, Liu YS (2006) Gamma knife treatment for pituitary prolactinomas. Zhong Nan Da Xue Xue Bao Yi Xue Ban 31(5):714–716

    PubMed  Google Scholar 

  54. Tinnel BA, Henderson MA, Witt TC, Fakiris AJ, Worth RM, Des Rosiers PM, Edmondson JW, Timmerman RD, Lo SS (2008) Endocrine response after gamma knife-based stereotactic radiosurgery for secretory pituitary adenoma. Stereotact Funct Neurosurg 86(5):292–296. doi:10.1159/000151717

    Article  PubMed  Google Scholar 

  55. Jezkova J, Hana V, Krsek M, Weiss V, Vladyka V, Liscak R, Vymazal J, Pecen L, Marek J (2009) Use of the Leksell gamma knife in the treatment of prolactinoma patients. Clin Endocrinol (Oxf) 70(5):732–741. doi:10.1111/j.1365-2265.2008.03384.x

    Article  Google Scholar 

  56. Sun DQ, Cheng JJ, Frazier JL, Batra S, Wand G, Kleinberg LR, Rigamonti D, Quinones-Hinojosa A, Salvatori R, Lim M (2010) Treatment of pituitary adenomas using radiosurgery and radiotherapy: a single center experience and review of literature. Neurosurg Rev 34(2):181–189. doi:10.1007/s10143-010-0285-2

    Article  PubMed  CAS  Google Scholar 

  57. Schalin-Jantti C, Valanne L, Tenhunen M, Setala K, Paetau A, Sane T, Kouri M (2010) Outcome of fractionated stereotactic radiotherapy in patients with pituitary adenomas resistant to conventional treatments: a 5.25-year follow-up study. Clin Endocrinol (Oxf) 73(1):72–77. doi:10.1111/j.1365-2265.2009.03755.x

    Google Scholar 

  58. Tanaka S, Link MJ, Brown PD, Stafford SL, Young WF Jr, Pollock BE (2010) Gamma knife radiosurgery for patients with prolactin-secreting pituitary adenomas. World Neurosurg 74(1):147–152. doi:10.1016/j.wneu.2010.05.007

    Article  PubMed  Google Scholar 

  59. McCord MW, Buatti JM, Fennell EM, Mendenhall WM, Marcus RB Jr, Rhoton AL, Grant MB, Friedman WA (1997) Radiotherapy for pituitary adenoma: long-term outcome and sequelae. Int J Radiat Oncol Biol Phys 39(2):437–444

    Article  PubMed  CAS  Google Scholar 

  60. Grabenbauer GG, Ernst-Stecken A, Schneider F, Lambrecht U, Ganslandt O (2006) Radiosurgery of functioning pituitary adenomas: comparison of different treatment techniques including dynamic and conformal arcs, shaped beams, and IMRT. Int J Radiat Oncol Biol Phys 66(Suppl 4):S33–S39

    Article  Google Scholar 

  61. Snyder PJ, Fowble BF, Schatz NJ, Savino PJ, Gennarelli TA (1986) Hypopituitarism following radiation therapy of pituitary adenomas. Am J Med 81(3):457–462

    Article  PubMed  CAS  Google Scholar 

  62. Littley MD, Shalet SM, Beardwell CG, Ahmed SR, Applegate G, Sutton ML (1989) Hypopituitarism following external radiotherapy for pituitary tumours in adults. Q J Med 70(262):145–160

    PubMed  CAS  Google Scholar 

  63. Parsons JT, Bova FJ, Fitzgerald CR, Mendenhall WM, Million RR (1994) Radiation optic neuropathy after megavoltage external-beam irradiation: analysis of time-dose factors. Int J Radiat Oncol Biol Phys 30(4):755–763

    Article  PubMed  CAS  Google Scholar 

  64. Jiang GL, Tucker SL, Guttenberger R, Peters LJ, Morrison WH, Garden AS, Ha CS, Ang KK (1994) Radiation-induced injury to the visual pathway. Radiother Oncol 30(1):17–25

    Article  PubMed  CAS  Google Scholar 

  65. Tomlinson JW, Holden N, Hills RK, Wheatley K, Clayton RN, Bates AS, Sheppard MC, Stewart PM (2001) Association between premature mortality and hypopituitarism. West Midlands Prospective Hypopituitary Study Group. Lancet 357(9254):425–431

    Article  PubMed  CAS  Google Scholar 

  66. Brada M, Burchell L, Ashley S, Traish D (1999) The incidence of cerebrovascular accidents in patients with pituitary adenoma. Int J Radiat Oncol Biol Phys 45(3):693–698

    Article  PubMed  CAS  Google Scholar 

  67. Erridge SC, Conkey DS, Stockton D, Strachan MW, Statham PF, Whittle IR, Grant R, Kerr GR, Gregor A (2009) Radiotherapy for pituitary adenomas: long-term efficacy and toxicity. Radiother Oncol 93(3):597–601. doi:10.1016/j.radonc.2009.09.011

    Article  PubMed  Google Scholar 

  68. Shimizu Y, Kodama K, Nishi N, Kasagi F, Suyama A, Soda M, Grant EJ, Sugiyama H, Sakata R, Moriwaki H, Hayashi M, Konda M, Shore RE (2010) Radiation exposure and circulatory disease risk: Hiroshima and Nagasaki atomic bomb survivor data, 1950–2003. BMJ 340:b5349

    Article  PubMed  Google Scholar 

  69. Minniti G, Traish D, Ashley S, Gonsalves A, Brada M (2005) Risk of second brain tumor after conservative surgery and radiotherapy for pituitary adenoma: update after an additional 10 years. J Clin Endocrinol Metab 90(2):800–804. doi:10.1210/jc.2004-1152

    Article  PubMed  CAS  Google Scholar 

  70. Mackley HB, Reddy CA, Lee SY, Harnisch GA, Mayberg MR, Hamrahian AH, Suh JH (2007) Intensity-modulated radiotherapy for pituitary adenomas: the preliminary report of the Cleveland Clinic experience. Int J Radiat Oncol Biol Phys 67(1):232–239. doi:10.1016/j.ijrobp.2006.08.039

    Article  PubMed  Google Scholar 

  71. Stafford SL, Pollock BE, Leavitt JA, Foote RL, Brown PD, Link MJ, Gorman DA, Schomberg PJ (2003) A study on the radiation tolerance of the optic nerves and chiasm after stereotactic radiosurgery. Int J Radiat Oncol Biol Phys 55(5):1177–1181

    Article  PubMed  Google Scholar 

  72. Akamatsu Y, Murakami K, Watanabe M, Jokura H, Tominaga T (2010) Malignant peripheral nerve sheath tumor arising from benign vestibular schwannoma treated by gamma knife radiosurgery after two previous surgeries: a case report with surgical and pathological observations. World Neurosurg 73(6):751–754. doi:10.1016/j.wneu.2010.04.009

    Article  PubMed  Google Scholar 

  73. Berman EL, Eade TN, Brown D, Weaver M, Glass J, Zorman G, Feigenberg SJ (2007) Radiation-induced tumor after stereotactic radiosurgery for an arteriovenous malformation: case report. Neurosurgery 61(5):E1099. doi:10.1227/01.neu.0000303207.92617.4e. discussion E1099

    Article  PubMed  Google Scholar 

  74. Comey CH, McLaughlin MR, Jho HD, Martinez AJ, Lunsford LD (1998) Death from a malignant cerebellopontine angle triton tumor despite stereotactic radiosurgery. Case report. J Neurosurg 89(4):653–658. doi:10.3171/jns.1998.89.4.0653

    Article  PubMed  CAS  Google Scholar 

  75. Kaido T, Hoshida T, Uranishi R, Akita N, Kotani A, Nishi N, Sakaki T (2001) Radiosurgery-induced brain tumor. Case report. J Neurosurg 95(4):710–713. doi:10.3171/jns.2001.95.4.0710

    Article  PubMed  CAS  Google Scholar 

  76. McIver JI, Pollock BE (2004) Radiation-induced tumor after stereotactic radiosurgery and whole brain radiotherapy: case report and literature review. J Neurooncol 66(3):301–305

    Article  PubMed  Google Scholar 

  77. Sasagawa Y, Akai T, Itou S, Iizuka H (2009) Gamma knife radiosurgery-induced cavernous hemangioma: case report. Neurosurgery 64(5):E1006–E1007. doi:10.1227/01.NEU.0000344005.23146.CC discussion E1007

    Article  PubMed  Google Scholar 

  78. Shamisa A, Bance M, Nag S, Tator C, Wong S, Noren G, Guha A (2001) Glioblastoma multiforme occurring in a patient treated with gamma knife surgery. Case report and review of the literature. J Neurosurg 94(5):816–821. doi:10.3171/jns.2001.94.5.0816

    Article  PubMed  CAS  Google Scholar 

  79. Sheehan J, Yen CP, Steiner L (2006) Gamma knife surgery-induced meningioma. Report of two cases and review of the literature. J Neurosurg 105(2):325–329. doi:10.3171/jns.2006.105.2.325

    Article  PubMed  Google Scholar 

  80. Shin M, Ueki K, Kurita H, Kirino T (2002) Malignant transformation of a vestibular schwannoma after gamma knife radiosurgery. Lancet 360(9329):309–310. doi:10.1016/S0140-6736(02)09521-1

    Article  PubMed  Google Scholar 

  81. Yu JS, Yong WH, Wilson D, Black KL (2000) Glioblastoma induction after radiosurgery for meningioma. Lancet 356(9241):1576–1577. doi:10.1016/S0140-6736(00)03134-2

    Article  PubMed  CAS  Google Scholar 

  82. Cahan WG, Woodard HQ et al (1948) Sarcoma arising in irradiated bone; report of 11 cases. Cancer 1(1):3–29

    Article  PubMed  CAS  Google Scholar 

  83. Grattan-Smith PJ, Morris JG, Shores EA, Batchelor J, Sparks RS (1992) Neuropsychological abnormalities in patients with pituitary tumours. Acta Neurol Scand 86(6):626–631

    Article  PubMed  CAS  Google Scholar 

  84. Peace KA, Orme SM, Thompson AR, Padayatty S, Ellis AW, Belchetz PE (1997) Cognitive dysfunction in patients treated for pituitary tumours. J Clin Exp Neuropsychol 19(1):1–6

    Article  PubMed  CAS  Google Scholar 

  85. Gondi V, Tome WA, Mehta MP (2010) Why avoid the hippocampus? A comprehensive review. Radiother Oncol 97(3):370–376. doi:10.1016/j.radonc.2010.09.013

    Article  PubMed  Google Scholar 

  86. Mahajan A, Dong L, Prabhu S, Wang C, Zhang Y, Lifei Z, Meyers C, Woo S (2007) Application of deformable image registration to hippocampal doses and neurocognitive outcomes. Soc Neuro Oncol 9:583

    Google Scholar 

  87. Mehta M (2011) RTOG 0933: a phase II trial of hippocampal avoidance during whole brain radiotherapy for brain metastases. http://www.rtog.org/ClinicalTrials/ProtocolTable/StudyDetails.aspx?study=0933

  88. Guinan EM, Lowy C, Stanhope N, Lewis PD, Kopelman MD (1998) Cognitive effects of pituitary tumours and their treatments: two case studies and an investigation of 90 patients. J Neurol Neurosurg Psychiatry 65(6):870–876

    Article  PubMed  CAS  Google Scholar 

  89. Armstrong CL, Hunter JV, Ledakis GE, Cohen B, Tallent EM, Goldstein BH, Tochner Z, Lustig R, Judy KD, Pruitt A, Mollman JE, Stanczak EM, Jo MY, Than TL, Phillips P (2002) Late cognitive and radiographic changes related to radiotherapy: initial prospective findings. Neurology 59(1):40–48

    Article  PubMed  CAS  Google Scholar 

  90. Brell M, Villa S, Teixidor P, Lucas A, Ferran E, Marin S, Acebes JJ (2006) Fractionated stereotactic radiotherapy in the treatment of exclusive cavernous sinus meningioma: functional outcome, local control, and tolerance. Surg Neurol 65(1):28–33. doi:10.1016/j.surneu.2005.06.027. discussion 33-24

    Article  PubMed  Google Scholar 

  91. Maguire PD, Clough R, Friedman AH, Halperin EC (1999) Fractionated external-beam radiation therapy for meningiomas of the cavernous sinus. Int J Radiat Oncol Biol Phys 44(1):75–79

    Article  PubMed  CAS  Google Scholar 

  92. Metellus P, Regis J, Muracciole X, Fuentes S, Dufour H, Nanni I, Chinot O, Martin PM, Grisoli F (2005) Evaluation of fractionated radiotherapy and gamma knife radiosurgery in cavernous sinus meningiomas: treatment strategy. Neurosurgery 57(5):873–886. discussion 873-886

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Radiation Oncology, Cleveland Clinic, 9500 Euclid Ave. T-28, Cleveland, OH, 44195, USA

    Lawrence J. Sheplan Olsen, Samuel T. Chao & John H. Suh

  2. Department of Neuro-Oncology, Cleveland Clinic, Cleveland, OH, USA

    Lizbeth Robles Irizarry

  3. Department of Neurosurgery, Cleveland Clinic, Cleveland, OH, USA

    Robert J. Weil

  4. Department of Endocrinology, Cleveland Clinic, Cleveland, OH, USA

    Amir H. Hamrahian & Betul Hatipoglu

Authors
  1. Lawrence J. Sheplan Olsen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Lizbeth Robles Irizarry
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Samuel T. Chao
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Robert J. Weil
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Amir H. Hamrahian
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Betul Hatipoglu
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. John H. Suh
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to John H. Suh.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sheplan Olsen, L.J., Robles Irizarry, L., Chao, S.T. et al. Radiotherapy for prolactin-secreting pituitary tumors. Pituitary 15, 135–145 (2012). https://doi.org/10.1007/s11102-011-0348-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11102-011-0348-6

Keywords

Search

Navigation